Cargando…
miR-93-5p suppresses ovarian cancer malignancy and negatively regulate CCND2 by binding to its 3′UTR region
Ovarian cancer is the most fatal gynecological cancer worldwide, yet the fundamental mechanism of malignancy acquisition in ovarian cancer remains unknown. miRNA has been implicated to a variety of diseases, including cancer initiation and progression. Cyclin-D2 (CCND2) is ubiquitously implicated in...
Autores principales: | Chen, Guotong, Yan, Yiwei, Qiu, Xiaojv, Ye, Chengfeng, Jiang, Xingmei, Song, Shuo, Zhang, Yibo, Chang, Huanhuan, Wang, Leqi, He, Xuehuan, Tang, Lingrong, Zhang, Qingyu, Zhang, Ying |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8934892/ https://www.ncbi.nlm.nih.gov/pubmed/35306579 http://dx.doi.org/10.1007/s12672-022-00478-1 |
Ejemplares similares
-
MiR-93-5p regulates tumorigenesis and tumor immunity by targeting PD-L1/CCND1 in breast cancer
por: Yang, Meng, et al.
Publicado: (2022) -
MiR-93 suppresses tumorigenesis and enhances chemosensitivity of breast cancer via dual targeting E2F1 and CCND1
por: Bao, Chang, et al.
Publicado: (2020) -
MicroRNA profiling identifies MiR-195 suppresses osteosarcoma cell metastasis by targeting CCND1
por: Han, Kang, et al.
Publicado: (2015) -
MiR-181a functions as an oncogene by regulating CCND1 in multiple myeloma
por: Yan, Xiao, et al.
Publicado: (2020) -
MiR-146a-5p inhibits cell proliferation and cell cycle progression in NSCLC cell lines by targeting CCND1 and CCND2
por: Li, Yan-Li, et al.
Publicado: (2016)